Examining diabetic nephropathy through the lens of mouse genetics

被引：6

作者：

Breyer M.D. ^{[1
]}

Tchekneva E. ^{[1
]}

Qi Z. ^{[1
]}

Takahashi T. ^{[1
]}

Fogo A.B. ^{[1
]}

Harris R.C. ^{[1
]}

机构：

[1] Biotherapeutics Discovery Research, Lilly Research Labs, Eli Lilly and Company, Indianapolis, IN 46225

来源：

Current Diabetes Reports | 2007年 / 7卷 / 6期

关键词：

Quantitative Trait Locus; Diabetic Nephropathy; Diabetic Mouse; Inbred Mouse; Recombinant Inbred;

D O I：

10.1007/s11892-007-0078-3

中图分类号：

学科分类号：

摘要：

Although diabetic nephropathy occurs in only a minority of patients with diabetes, it is the major cause of end-stage renal disease in the United States. Hyperglycemia and hypertension are important factors predisposing patients to diabetic nephropathy, but accumulating evidence points to critical genetic factors predisposing only a subset of patients with diabetes to nephropathy. It has been challenging to define the genes conferring risk for nephropathy in human populations. Comparative genomics using the robust genetic reagents available in laboratory mice should provide a complementary approach to defining genes that may predispose to diabetic nephropathy in mice and humans. This article reviews new studies to identify genetic risk factors for diabetic nephropathy and the unique approaches that may be used to elucidate the genetic pathogenesis of this disorder in mice. Copyright © 2007 by Current Medicine Group LLC.

引用

页码：459 / 466

页数：7

共 67 条

[1] Parving H.H., Initiation and progression of diabetic nephropathy, N Engl J Med, 335, pp. 1682-1683, (1996)
[2] Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group [no authors listed], N Engl J Med, 342, pp. 381-389, (2000)
[3] Krolewski M., Eggers P.W., Warram J.H., Magnitude of end-stage renal disease in IDDM: A 35 year follow-up study, Kidney Int, 50, pp. 2041-2046, (1996)
[4] Knowler W.C., Coresh J., Elston R.C., Et al., The Family Investigation of Nephropathy and Diabetes (FIND): Design and methods, J Diabetes Complications, 19, pp. 1-9, (2005)
[5] Seaquist E.R., Goetz F.C., Rich S., Barbosa J., Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy, N Engl J Med, 320, pp. 1161-1165, (1989)
[6] Iyengar S.K., Abboud H.E., Goddard K.A.B., Et al., Genome-wide scans for diabetic nephropathy and albuminuria in multi-ethnic populations: The Family Investigation of Nephropathy and Diabetes, Diabetes, 56, pp. 1577-1585, (2007)
[7] Chavers B.M., Bilous R.W., Ellis E.N., Et al., Glomerular lesions and urinary albumin excretion in type I diabetes without overt proteinuria, N Engl J Med, 320, pp. 966-970, (1989)
[8] Breyer M.D., Bottinger E., Brosius 3rd F.C., Et al., Mouse models of diabetic nephropathy, J Am Soc Nephrol, 16, pp. 27-45, (2005)
[9] Beck J.A., Lloyd S., Hafezparast M., Et al., Genealogies of mouse inbred strains, Nat Genet, 24, pp. 23-25, (2000)
[10] Wade C.M., Daly M.J., Genetic variation in laboratory mice, Nat Genet, 37, pp. 1175-1180, (2005)

← 1 2 3 4 5 6 7 →